2010
DOI: 10.1016/j.jbusres.2009.10.004
|View full text |Cite
|
Sign up to set email alerts
|

Marketing and societal welfare: A multiple stakeholder approach

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 55 publications
1
3
0
Order By: Relevance
“…This research enhances our knowledge regarding the effect of marketing tools such as conferences, symposium, travel... [6,7].…”
Section: A Marketing Toolssupporting
confidence: 53%
See 1 more Smart Citation
“…This research enhances our knowledge regarding the effect of marketing tools such as conferences, symposium, travel... [6,7].…”
Section: A Marketing Toolssupporting
confidence: 53%
“…According to Matear & Dacin Marketing actions influence the way individuals and organizations understand and act upon different issues [6].…”
Section: The Pharmaceutical Industry Effect On Doctors' Prescriptionmentioning
confidence: 99%
“…This is a form a distributive injustice, violating the fourth essential moral precept for enlightened marketing proposed by Laczniak and Murphy (2006). Taking a stakeholder approach can lead to improved social well-being (Laczniak and Murphy 2006; Matear and Dacin 2010). Understanding how marketers impact the interests of various stakeholders is a subject of interest for Macromarketing (Nason 2006).…”
Section: Literature Reviewmentioning
confidence: 99%
“…For example, a physician will act as an agent for a patient by using their medical knowledge to diagnose a patient's illness and prescribe an appropriate medication. Importantly, physicians not only act as agents for patients but also are principals themselves, relying on pharmaceutical representatives to act as agents on their behalf (Matear and Dacin 2010). The industry is thus organized such that the two primary consumers of pharmaceutical products—the physician who prescribes them and the patient who uses them—are each intentionally shielded from vast amounts of information and must rely on others, especially pharmaceutical marketers, to make decisions for them.…”
Section: Theme 2: Information Flow Across the Pharmaceutical Industrymentioning
confidence: 99%